Development of a novel biomarker test for autism risk screening

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$700,358.00
Award Year:
2012
Program:
SBIR
Phase:
Phase I
Contract:
1R43ES022160-01
Award Id:
n/a
Agency Tracking Number:
R43ES022160
Solicitation Year:
2012
Solicitation Topic Code:
NIEHS
Solicitation Number:
PA09-045
Small Business Information
505 COAST BLVD SOUTH, SUITE 309, LA JOLLA, CA, -
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
783973212
Principal Investigator:
SERGEI SVAROVSKY
(619) 718-1347
sergei.svarovsky@gmail.com
Business Contact:
SERGEI SVAROVSKY
(619) 718-1347
ssvarovsky@xenbiosciences.com
Research Institute:
Stub




Abstract
DESCRIPTION (provided by applicant): Autism spectrum disorders (ASD) currently affect about 1 in 110 children in the US, and are associated with a high economic cost to both families and society. There are currently no consistent biological markers for Autism, and diagnosis is currently based upon analysis of behavioral traits and developmental history. The most beneficial treatment for ASD is behavioral therapy, which is most effective if administered early in life. We have previously identified and validated a set of protein biomarkers for autism risk in the plasma of women from a large cohort of mothers of children with autism and unaffected controls. The main goal of the proposed research is to develop a multiplex quantitative assay for these biomarkersto be able to predict the risk of having a child with autism, prior to pregnancy, especially in those mothers who have at least one child with autism and are at elevated risk of having a second child on the spectrum. This test can also be used post-natally to determine if a child is at risk based on the maternal autoantibody profile. To achieve this goal we propose the following three Specific Aims: Aim #1: Express LDH-A, LDH-B, Cypin, STIP1, CRMP1, and CRIMP2 proteins in both a mammalian and prokaryotic expression systems. To evaluate the immunoreactivity of the endogenous autoantibodies from mothers of children with autism and typically developing controls against these expressed proteins. Aim #2: Develop high throughput multiplexed assays for LDH, Cypin,STIP1 and CRMP1. Produce standard curve of autoantibody concentration vs. signal in buffer and plasma and evaluate assay accuracy, precision, and sensitivity. Aim #3: Validation studies with blinded serum sets using the newly developed multiplex assays will be used to correlate the concentration of each of these endogenous autoantibodies to the development of disease in samples taken from mothers during pregnancy that gave birth to a child with autism vs. mothers that give birth to typically developing child, and establish a threshold for a positive prognosis with 99% confidence. The project will result in a diagnostic product that will give women an opportunity to know if they are at risk of having a child with autism prior to conception, thereby allowingthe possibility to take preventative steps and early intervention. PUBLIC HEALTH RELEVANCE: Autism spectrum disorders (ASD) currently affect about 1 in 110 children in the US, and are associated with a high economic cost to both families and society. There are currently no consistent biological markers for autism, and diagnosis is currently based upon analysis of behavioral traits and developmental history. We propose to develop a multiplex quantitative assay for these biomarkers to be able to predict the risk of having a child with autism, prior to pregnancy, especially in those mothers who have at least one child with autism and are at elevated risk of having a second child on the spectrum.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government